Log in

Relevant bibliographies by topics / Pharmaceutical producers / Books

Books on the topic 'Pharmaceutical producers'

To see the other types of publications on this topic, follow the link: Pharmaceutical producers.

Author: Grafiati

Published: 10 December 2022

Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Pharmaceutical producers.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Vaccine nation: A thriller. Las Vegas, NV]: Thomas & Mercer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Institute, Pennsylvania Bar. Pharmaceutical litigation. [Mechanicsburg, Pa.]: Pennsylvania Bar Institute, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Fissore, Davide, Roberto Pisano, and Antonello Barresi, eds. Freeze Drying of Pharmaceutical Products. Boca Raton : CRC Press, [2020] | Series: Advances in drying science and technology: CRC Press, 2019. http://dx.doi.org/10.1201/9780429022074.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Canada. Library of Parliament. Research Branch., ed. Patent protection for pharmaceutical products. [Ottawa]: Library of Parliament, Research Branch, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Attaway, David H., and Oskar R. Zaborsky, eds. Pharmaceutical and Bioactive Natural Products. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4899-2391-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Schaumann, Leif. Pharmaceutical industry perspectives: Japanese pharmaceutical internationalization. Menlo Park, CA (333 Ravenswood Ave., Menlo Park 94025-3493): SRI International, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Birkinshaw, F. L. Analytical procedures for chiral pharmaceutical products. Manchester: UMIST, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Merkus, Henk G., Gabriel M. H. Meesters, and Wim Oostra, eds. Particles and Nanoparticles in Pharmaceutical Products. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-94174-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Pal, Dilipkumar, and Amit Kumar Nayak, eds. Bioactive Natural Products for Pharmaceutical Applications. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54027-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Canada, Canada Industry. Chemicals, pharmaceuticals and plastics: Forest products. Ottawa, Ont: Industry Canada, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Paine, Frank A. Packaging of pharmaceuticals and healthcare products. [S.l.]: Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Lockhart, H., and F. A. Paine. Packaging of Pharmaceuticals and Healthcare Products. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4615-2125-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Report, Industries Assistance Commission. Pharmaceutical Products (Penicillin Bounty) Dec. 11, 1985. Canberra: Australian Government Publishing Services, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Thadani, M. B. Medicinal and pharmaceutical uses of natural products. 2nd ed. Winnipeg: Cantext Publications, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Halls, Nigel A. Achieving sterility in medical and pharmaceutical products. New York: Marcel Dekker, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Shadlen, Kenneth C. Power to the Producers. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780199593903.003.0003.

Full text

Abstract:

This chapter analyses Argentina’s minimalist response to the global sea change. The pathway from the President Menem’s 1991 proposal for a new patent law to the 1996 Law on Invention Patents and Utility Models reveals intense Executive–Legislative conflict over how Argentina should introduce drug patents. The US Government and the Argentine Executive fought tirelessly for over-compliance, but failed to secure this outcome. Argentina’s national pharmaceutical firms were able to construct a broad coalition against over-compliance, benefiting from its own considerable resources as well as the support of other actors in the industrial sector and health community. In contrast, the transnational sector was unable to attract allies that could widen its own coalition, as the country’s export structure meant that the principal instrument used to expand coalitions for over-compliance was ineffective. By the end of the 1990s, minimalism had become state policy in Argentina.

APA, Harvard, Vancouver, ISO, and other styles

17

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Pharmaceutical Products. Stationery Office Books, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Pharmaceutical Products. Stationery Office Books, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Pharmaceutical Products. Stationery Office Books, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Pharmaceutical Products. Stationery Office Books, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Pharmaceutical Products. Stationery Office Books, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Limited, REMIT Consultants, Commission of the European Communities. Directorate-General for Internal Market and Financial Services., and Commission of the European Communities. Directorate-General for Economic and Financial Affairs., eds. Pharmaceutical products. London: Kogan Page, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Pharmaceutical Products. Stationery Office Books, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Pharmaceutical Products. Stationery Office Books, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Britain, Great. Pharmaceutical Products. Stationery Office Books, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Fernandez, Benjamin Adolfo. Liofilizacion De Productos Farmaceuticos / Lyophilization of Pharmaceutical Products. Editorial Limusa S.A. De C.V., 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Vairappan, Charles S. Ecological Chemicals as Ecosystem Function Mediaters and Potential Lead Pharmaceuticals. UMS Press, 2021. http://dx.doi.org/10.51200/ecologicalchemicalsumspress2021-978-967-2962-94-6.

Full text

Abstract:

Relationship between functioning ecosystem services and human wellbeing has been established as a bridge connecting nature and society. It has also become central pillar of sustainability science and dictates the paradigms of sustainable development. But, conceptual frameworks that systematically integrates the important roles played by natural ecological chemicals by establishing empirical links between the nature and ecology not only varies, but lacks clear support. The value of ecological chemicals as ecosystem derived natural products warrants explicit acknowledgement, only then trade-offs between services and prioritization of policy can be realised. In the last 20 years, important roles played by the ecological chemicals in Bornean terrestrial and marine ecosystems were investigated and reported. Terrestrial plants produce Volatile Organic Chemicals (VOCs) and structurally interesting secondary metabolites that facilitate their ecological processes that are aimed to establish communication such as defence, attraction, deterrent and territorial marking. Some of the most commonly utilized herbs and plants of traditional medicine importance showed very interesting chemical constituents, that justify their traditional utilization for human wellbeing. The role of VOCs that originated from animal diet and emitted through decomposition of faeces, was traced back to their important role as attractants of insects, particularly dung beetles that facilitates the remineralization of faeces and returns C and N to soil as to replenish global C and N-sink. Marine flora and fauna are perhaps the most vivid producers of structurally interesting secondary metabolites with more than one ecological functions. Halogenated secondary metabolites produced by red algae Laurencia are unique in their structural design and exhibited multiple biological potentials. Similarly, soft corals in the Sulu-Sulawesi Coral Triangle produced a huge diversity of terpenoids and functions as feeding deterrents of these soft bodied invertebrates. Ecological chemicals obtained from the Bornean biodiversity also exhibited a wide array of medically important biological activities such as anti-microbial, anti-inflammation, anti-anticancer and serves an important array of lead pharmaceuticals. Some of these compounds are very potent and have been patented as lead-pharmaceutical candidates from Bornean natural products. Hence, ecological chemicals are important natural products that regulate ecological processes that ensures ecological balance in tropical ecosystems. Humans who are the custodians of natural ecosystem, stand to benefit directly and indirectly when we practice sustainable utilization and regulation of our natural resources.

APA, Harvard, Vancouver, ISO, and other styles

40

Shadlen, Kenneth C. The Political Economy of Pharmaceutical Patents. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780199593903.003.0002.

Full text

Abstract:

The chapter provides brief introductions to intellectual property, patents, and pharmaceuticals to help the reader understand the nature of the enduring conflicts in this area. Prior to the 1990s few developing countries granted patents on pharmaceutical products, but changes in the global politics of intellectual property made doing so obligatory – the starting point for the analyses in this book. The chapter reviews the policy challenges that countries addressed in deciding how to introduce pharmaceutical patents and then in revising their new patent systems, and then presents the explanatory framework to account for cross-national and longitudinal variation. National forms of compliance with global changes are iterative and path-dependent processes, in that there are successive episodes of conflict, and the policy choices of one period exert influence on the policy choices in subsequent periods. Degrees of over-compliance with the new global order are produced through resolution of these two sets of conflicts.

APA, Harvard, Vancouver, ISO, and other styles

41

OTC pharmaceutical products. 5th ed. Hampton: Key Note Publications, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Publications, Key Note, ed. OTC pharmaceutical products. 3rd ed. Hampton: Key Note Publications, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

OTC pharmaceutical products. London: Key Note Publications, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Publications, Key Note, ed. Prescribed pharmaceutical products. 9th ed. Hampton: Key Note Publications, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Publications, Key Note, ed. OTC pharmaceutical products. 2nd ed. Hampton: Key Note Publications, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Publications, Key Note, ed. Prescribed pharmaceutical products. London: Key Note Publications., 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Publications, Key Note, ed. OTC pharmaceutical products. 4th ed. Hampton: Key Note Publications, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Schweitzer, Stuart O., and Z. John Lu. The Pharmaceutical Industry. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190623784.003.0002.

Full text

Abstract:

Understanding the pharmaceutical industry is a complex mission, requiring a thorough understanding not only of the firms that produce drugs but also of the decision-making process involved in drug selection for patients, the role of insurance and other third-party payers, and the substantial role of government in monitoring and regulating many aspects of the marketplace for pharmaceuticals. This chapter provides an overview of the pharmaceutical industry, including the market structure, the stages of research and development (R&D) and the associated costs, the role of government regulation in R&D and approval, and the role of product liability in the research process. It notes the important distinction between basic research and applied research, and explains the roles of the private and public sectors in each. The chapter ends with a discussion of the development of pharmaceuticals for poor countries.

APA, Harvard, Vancouver, ISO, and other styles

49

Schweitzer, Stuart O., and Z. John Lu. Pharmaceutical Economics and Policy. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190623784.001.0001.

Full text

Abstract:

Pharmaceuticals play a critical role in the raging debate over how best to advance and improve healthcare in the United States and the rest of the world. Using the analytical tools of economics, this book explores the conflicting priorities and aims of the biopharmaceutical industry. It starts out by describing the supply side of pharmaceuticals in all its forms, including the traditional pharmaceutical sector, the biotechnology sector, and the generic sector, as well as the increased blending among them. It next turns to the demand side, looking at the determinants of demand for pharmaceutical products. It discusses third-party payer coverage and patient access issues, and considers pharmaceutical demand factors in both emerging markets and industrialized parts of the world. Drawing extensively from recent economics and policy literatures, this book examines if and how a drug’s pricing strategy is influenced by clinical and economic attributes, characteristics of third-party payers, cost of research and development, competition from other branded drugs and generics, and other factors. An in-depth analysis looks at various drug promotional programs, their effectiveness in influencing demand and price, and the corresponding controversies and ensuing public debates. The focus of the book then turns toward pharmaceutical regulation, including the patent system, the approval process for both branded and generic drugs, the regulation of drug promotion, and major drug legislations since the beginning of the twentieth century. The book concludes by offering a look ahead at evolving industry structure, research methods, product characteristics, financing mechanisms, and regulatory policies affecting both price and access to pharmaceuticals worldwide.

APA, Harvard, Vancouver, ISO, and other styles

50

Developing Generic Pharmaceutical Products. Technomic Publishing Co, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!